These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
106 related articles for article (PubMed ID: 209232)
21. [Bone scintigraphy with 99mTc-labeled methylene diphosphonate in hemodialysis patients (author's transl)]. Yamashita M; Aoki T; Kakiuchi T; Mabuchi H; Tabata Y; Murao Y; Nishizawa H; Maruyama Y; Kishi Y; Nakahashi H; Murakami K Radioisotopes; 1981 Nov; 30(11):609-11. PubMed ID: 6461029 [No Abstract] [Full Text] [Related]
22. [Clinical study on bone metastases from bronchogenic carcinoma by bone scintigraphy with 99mTc-phosphorous compounds. III. The ability of detection by bone scintigraphy and roentgenography in bone destructed by Pancoast's tumor (author's transl)]. Fujimura N Nihon Igaku Hoshasen Gakkai Zasshi; 1979 Sep; 39(9):984-92. PubMed ID: 514803 [No Abstract] [Full Text] [Related]
23. [Retrospective study of renal images on bone scans]. Murayama T; Munakata A; Narita K; Fujita K; Fujii K Rinsho Hoshasen; 1989 Mar; 34(3):335-8. PubMed ID: 2739084 [TBL] [Abstract][Full Text] [Related]
24. [Clinical study on bone metastases from bronchogenic carcinoma by bone scintigraphy with 99mTc-phosphorous compounds. II. Comparison between bone scintigraphy and roentgenographic findings and their assessments (author's transl)]. Fujimura N Nihon Igaku Hoshasen Gakkai Zasshi; 1979 Jun; 39(6):627-36. PubMed ID: 482079 [No Abstract] [Full Text] [Related]
25. [Clinical evaluation of bone metastases from carcinoma of the prostate by bone scintigraphy with 99mTc-phosphorous compounds (author's transl)]. Bussaka H; Fujimura N; Yamasaki K Kaku Igaku; 1980 Apr; 17(3):297-303. PubMed ID: 7392308 [No Abstract] [Full Text] [Related]
26. [Usefullness of bone scintigraphy in vibration disease (author's transl)]. Kida T; Narita S; Higuchi Y Kaku Igaku; 1981 Mar; 18(2):183-93. PubMed ID: 6454800 [No Abstract] [Full Text] [Related]
27. [Evaluation of osteolytic lesion by dynamic bone scintigraphy (author's transl)]. Kumano M; Ushio K; Suematsu T; Kawai K; Mizuno K; Kajita A; Ishida O Kaku Igaku; 1980 Sep; 17(8):911-9. PubMed ID: 7218587 [No Abstract] [Full Text] [Related]
28. [Clinical evaluation of various bone diseases by 99mTc-MDP (author's transl)]. Tobari C; Fukuoka Y; Kanaumi H; Murai M; Ajima M; Kurosawa H Kaku Igaku; 1978 Apr; 15(2):267-74. PubMed ID: 671868 [No Abstract] [Full Text] [Related]
29. [Clinical evaluation of bone scintigraphy with 99mTc-labeled phosphate compounds. I. Metastatic bone tumor (author's transl]. Yamamoto I Nihon Igaku Hoshasen Gakkai Zasshi; 1978 Sep; 38(9):862-78. PubMed ID: 101970 [No Abstract] [Full Text] [Related]
31. Effects of renal failure and metabolic diseases upon bone scanning in children. Schümichen C Ann Radiol (Paris); 1983; 26(6):498-504. PubMed ID: 6316830 [No Abstract] [Full Text] [Related]
32. [Clinical evaluation of bone scan using Tc-99m methylene diphosphonate (author's transl)]. Kado B; Nakajima T; Sakura M; Sasaki Y; Nagai T Kaku Igaku; 1979 Feb; 16(1):95-103. PubMed ID: 439497 [No Abstract] [Full Text] [Related]
33. [An evaluation of 99mTc-hydroxymethylene diphosphonate (99mTc-HMDP) as a new bone scanning agent (author's transl)]. Hayashi M; Takahashi K; Furukawa K; Hazue M; Shibatsuji H; Yasuda N; Tanaka K; Yoshikawa I; Maeda K; Hamada S Radioisotopes; 1981 Jan; 30(1):38-9. PubMed ID: 7268059 [No Abstract] [Full Text] [Related]